First Foundation Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.54M | Sell |
136,479
-29,718
| -18% | -$2.08M | 0.35% | 51 |
|
|
2025
Q1 | $12.2M | Sell |
166,197
-23,974
| -13% | -$1.76M | 0.5% | 44 |
|
|
2024
Q4 | $12.5M | Sell |
190,171
-14,241
| -7% | -$933K | 0.47% | 50 |
|
|
2024
Q3 | $15.9M | Sell |
204,412
-22,426
| -10% | -$1.75M | 0.6% | 39 |
|
|
2024
Q2 | $17.7M | Buy |
226,838
+3,669
| +2% | +$286K | 0.68% | 37 |
|
|
2024
Q1 | $15.1M | Buy |
223,169
+56,700
| +34% | +$3.84M | 0.61% | 41 |
|
|
2023
Q4 | $11.2M | Sell |
166,469
-38,227
| -19% | -$2.57M | 0.51% | 53 |
|
|
2023
Q3 | $13.9M | Buy |
204,696
+52,879
| +35% | +$3.58M | 0.65% | 41 |
|
|
2023
Q2 | $10.9M | Buy |
+151,817
| New | +$10.9M | 0.47% | 55 |
|